f The Relationship among SARS-CoV-2, Vaccine Spike Protein, Renin-Angiotensin System, and Epilepsy

References

1. Epilepsy.2024Available from: https://www.who.int/news-room/fact-sheets/detail/epilepsy
2. OoiQ.Y. QinX. YuanY. Alteration of excitation/inhibition imbalance in the hippocampus and amygdala of drug-resistant epilepsy patients treated with acute vagus nerve stimulation.Brain Sci.202313797610.3390/brainsci13070976 37508908
   [Google Scholar]
3. AnwarH. KhanQ.U. NadeemN. PervaizI. AliM. CheemaF.F. Epileptic seizures.Discoveries 202082e11010.15190/d.2020.7 32577498
   [Google Scholar]
4. ChenZ. BrodieM.J. DingD. KwanP. Editorial: Epidemiology of epilepsy and seizures.Front. in Epidemiol.20233127316310.3389/fepid.2023.1273163 38455942
   [Google Scholar]
5. FiestK.M. SauroK.M. WiebeS. Prevalence and incidence of epilepsy.Neurology201788329630310.1212/WNL.0000000000003509 27986877
   [Google Scholar]
6. BeghiE. GiussaniG. Aging and the epidemiology of epilepsy.Neuroepidemiology2018513-421622310.1159/000493484 30253417
   [Google Scholar]
7. Combined generalized and focal epilepsy.2024Available from: https://www.epilepsydiagnosis.org/epilepsy/focal-generalized-epilepsy-groupoverview.html
8. Epilepsy - Symptoms.2017Available from: https://www.nhs.uk/conditions/epilepsy/symptoms/
9. FajlounZ. WuY. CaoZ. KovacicH. SabatierJ.M. COVID-19 and alzheimer’s disease: The link finally established.Infect. Disord. Drug Targets20232371416 37254552
   [Google Scholar]
10. KrasniqiS. DaciA. Role of the angiotensin pathway and its target therapy in epilepsy management.Int. J. Mol. Sci.201920372610.3390/ijms20030726 30744022
    [Google Scholar]
11. FajlounZ. SabatierJ.M. The unsuspected role of the renin-angiotensin system (RAS): Could its dysregulation be at the root of all non-genetic human diseases?Infect. Disord. Drug Targets2024241e14092322108510.2174/1871526524666230914114524 37711109
    [Google Scholar]
12. DzauV.J. BernsteinK. CelermajerD. The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data.Am. J. Cardiol.200188912010.1016/S0002‑9149(01)01878‑1 11694220
    [Google Scholar]
13. KaschinaE. UngerT. Angiotensin AT1/AT2 receptors: Regulation, signalling and function.Blood Press.2003122708810.1080/08037050310001057 12797627
    [Google Scholar]
14. CareyR.M. Update on the role of the AT2 receptor.Curr. Opin. Nephrol. Hypertens.2005141677110.1097/00041552‑200501000‑00011 15586018
    [Google Scholar]
15. El-ArifG. FarhatA. KhazaalS. The renin-angiotensin system: A key role in sars-cov-2-induced COVID-19.Molecules20212622694510.3390/molecules26226945 34834033
    [Google Scholar]
16. AnnweilerC. CaoZ. WuY. Counter-regulatory ‘renin-angiotensin’ system-based candidate drugs to treat COVID-19 diseases in sars-cov-2-infected patients.Infect. Disord. Drug Targets202020440740810.2174/22123989MTA2cNzIlw 32418532
    [Google Scholar]
17. El-ArifG. KhazaalS. FarhatA. Angiotensin II type i receptor (AT1R): The gate towards COVID-19-associated diseases.Molecules2022277204810.3390/molecules27072048 35408447
    [Google Scholar]
18. KhazaalS. HarbJ. RimaM. The pathophysiology of long COVID throughout the renin-angiotensin system.Molecules2022279290310.3390/molecules27092903 35566253
    [Google Scholar]
19. SabatierJ-M. FajlounZ. LegrosC. COVID-19 and ehlers-danlos syndrome: The dangers of the spike protein of sars-cov-2.Infect. Disord. Drug Targets2023233e04012321237510.2174/1871526523666230104145108 36600622
    [Google Scholar]
20. FajlounZ. Abi KhattarZ. KovacicH. LegrosC. SabatierJ.M. Why do athletes develop very severe or fatal forms of COVID after intense exercise following sars-cov-2 infection or anti-COVID vaccination?Infect. Disord. Drug Targets2023234e11012321256310.2174/1871526523666230111104355 36631923
    [Google Scholar]
21. FajlounZ. Abi KhattarZ. KovacicH. LegrosC. SabatierJ.M. SIBO: The trail of a “new” human pathology associated with multiple severe and disabling COVID-19 and long COVID symptoms or induced by the anti-COVID-19 vaccine.Infect. Disord. Drug Targets2023234e10022321359310.2174/1871526523666230210162334 36762752
    [Google Scholar]
22. FajlounZ. Abi KhattarZ. KovacicH. LegrosC. SabatierJ.M. Anti-COVID-19 vaccination, COVID-19, and female contraception: The exacerbated risks (thromboembolism) of the estrogen-progestin pill.Infect. Disord. Drug Targets2023234e24022321400010.2174/1871526523666230224094439 36823996
    [Google Scholar]
23. FajlounZ. Abi KhattarZ. KovacicH. LegrosC. SabatierJ.M. Understanding and relieving of neuropathic disorders in the long COVID.Infect. Disord. Drug Targets2023234e27022321406110.2174/1871526523666230227113205 36843369
    [Google Scholar]
24. FajlounZ. Abi KhattarZ. KovacicH. SabatierJ.M. COVID-19 and anti-COVID-19 vaccination: potential damages to the thyroid gland.Infect. Disord. Drug Targets2023236e09052321669810.2174/1871526523666230509112038 37165584
    [Google Scholar]
25. FajlounZ. WuY. CaoZ. KovacicH. SabatierJ.M. COVID-19 and parkinson’s disease: the link also established!Infect. Disord. Drug Targets2023 37340743
    [Google Scholar]
26. FajlounZ. KhattarZ.A. SabatierJ.M. The intriguing connection between cholestasis and the renin-angiotensin system dysregulation induced by sars-cov-2 and/or the vaccinal spike protein.Infect. Disord. Drug Targets2024247e08032422780210.2174/0118715265304515240220105152 38465438
    [Google Scholar]
27. TajerL. PaillartJ.C. DibH. SabatierJ.M. FajlounZ. Abi KhattarZ. Molecular mechanisms of bacterial resistance to antimicrobial peptides in the modern era: An updated review.Microorganisms2024127125910.3390/microorganisms12071259 39065030
    [Google Scholar]
28. FajlounZ. Abi KhattarZ. SabatierJ.M. SARS-CoV-2 or vaccinal spike protein can induce mast cell activation syndrome (MCAS).Infect. Disord. Drug Targets20242413 38693735
    [Google Scholar]
29. FajlounZ. TajerL. KhattarZ.A. SabatierJ.M. Unveiling the role of SARS-CoV-2 or mRNA vaccine spike protein in macrophage activation syndrome (MAS).Infect. Disord. Drug Targets202424 39041264
    [Google Scholar]
30. QuarleriJ. DelpinoM.V. SARS-CoV-2 interacts with renin-angiotensin system: Impact on the central nervous system in elderly patients.Geroscience202244254756510.1007/s11357‑022‑00528‑0 35157210
    [Google Scholar]
31. Soltani ZangbarH. GorjiA. GhadiriT. A review on the neurological manifestations of COVID-19 infection: A mechanistic view.Mol. Neurobiol.202158253654910.1007/s12035‑020‑02149‑0 32981023
    [Google Scholar]
32. IvanovaN. TchekalarovaJ. The potential therapeutic capacity of inhibiting the brain renin–angiotensin system in the treatment of co-morbid conditions in epilepsy.CNS Drugs201933111101111210.1007/s40263‑019‑00678‑4 31680223
    [Google Scholar]
33. CascellaM. RajnikM. AleemA. DulebohnS.C. Di NapoliR. Features, evaluation, and treatment of coronavirus (COVID-19).In: StatPearls.Treasure Island, FLStatPearls Publishing2024
    [Google Scholar]
34. Al-JamalH. IdrissS. RoufayelR. Abi KhattarZ. FajlounZ. SabatierJ.M. Treating COVID-19 with medicinal plants: Is it even conceivable? A comprehensive review.Viruses202416332010.3390/v16030320 38543686
    [Google Scholar]
35. DongX. FanJ. LinD. Captopril alleviates epilepsy and cognitive impairment by attenuation of C3-mediated inflammation and synaptic phagocytosis.J. Neuroinflammation202219122610.1186/s12974‑022‑02587‑8 36104755
    [Google Scholar]
36. GomesK.P. BragaP.P.P. de LimaC.Q.Jr Antiepileptic effects of long-term intracerebroventricular infusion of angiotensin-(1-7) in an animal model of temporal lobe epilepsy.Clin. Sci.2020134172263227710.1042/CS20200514 32803259
    [Google Scholar]
37. DoegeC. LueddeM. KostevK. Association between angiotensin receptor blocker therapy and incidence of epilepsy in patients with hypertension.JAMA Neurol.202279121296130210.1001/jamaneurol.2022.3413 36251288
    [Google Scholar]